Randomized controlled trial: the safety and efficacy of adjunctive corticosteroids through the clinical course of severe hospital-acquired pneumonia
Background Pneumonia acquired in hospitals (HAP) is a nosocomial infection that poses the greatest risk of death and serious sequelae. Aim This study’s objective was to assess safety and efficacy of adjunctive systemic steroids in individuals who have severe HAP including ventilator-associated pneum...
Saved in:
| Main Authors: | Safaa M. M. Wafy, Hassan A.-E. H. Bayoumi, Rabab H. Hassan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Egyptian Journal of Chest Disease and Tuberculosis |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/ecdt.ecdt_8_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucocorticoids can reduce mortality in patients with severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials
by: Xue Gu, et al.
Published: (2025-03-01) -
Korean Guidelines for the Management and Antibiotic Therapy in Adult Patients with Hospital-Acquired Pneumonia
by: Hayoung Choi, et al.
Published: (2025-01-01) -
Incidence of nosocomial pneumonia in two intensive care units of a French University Hospital from 2016 to 2022 in the era of COVID-19 pandemic
by: Sélilah Amour, et al.
Published: (2025-06-01) -
Community versus academic hospital community-acquired pneumonia patients: a nested cohort study
by: Jennifer L.Y. Tsang, et al.
Published: (2024-11-01) -
Predictive value of different severity scoring systems in patients with community acquired pneumonia
by: Amira H. Allam, et al.
Published: (2025-01-01)